Article
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2001
Honjo Y, Nangia-Makker P, Inohara H, Raz A
Abstract excerpt
Galectin-3 is an endogenous beta-galactoside-binding protein with specificity for type I and II ABH blood group epitopes and poly-N-acetyllactosamine glycan-containing cell surface glycoproteins and is the major nonintegrin cellular laminin-binding protein. Galectin-3 is expressed at an elevated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
